Meridian Bioscience reported $328.3M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US -39747000 30M
Atrion ATRI:US 239.28M 1.44M
Becton, Dickinson and BDX:US $ 23677M 458M
Bio Rad Laboratories BIO:US $ 15332.38M 3737.5M
Cerulean Pharma CERU:US $ 31.89M 24.14M
Cerus CERS:US $ 80.08M 4.16M
Genmark Diagnostics GNMK:US $ 94.2M 0.24M
Luminex LMNX:US $ 488.05M 29.66M
Meridian Bioscience VIVO:US $ 328.3M 6.15M
Myriad Genetics MYGN:US $ 968.6M 66.1M
Neogen NEOG:US $ 855.36M 14.99M
Orasure Technologies OSUR:US $ 387.82M 17M
Oxford Immunotec Global OXFD:US $ 191.26M 2.37M
Quidel QDEL:US $ 1634.07M 222.99M
Rockwell Medical RMTI:US $ 11.09M 7.11M
Sientra SIEN:US $ 40.76M 71.64M
Staar Surgical STAA:US $ 249.11M 14.49M
Thermo Fisher Scientific TMO:US $ 38710M 1856M
Trinity Biotech TRIB:US $ -0.5M 0.37M
Utah Medical Products UTMD:US $ 109.98M 5.1M